Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Active versus Passive Immunity01:31

Active versus Passive Immunity

9.7K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
9.7K
Vaccinations01:51

Vaccinations

50.9K
Overview
50.9K
Immunological Memory01:23

Immunological Memory

14.7K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.7K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.2K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological and toxicological assessment of a potential GnRH vaccine in young-adult male pigs.

Vaccine·2011
Same author

Monitoring health by values of acute phase proteins.

Acta histochemica·2006
Same author

GnRH tandem peptides for inducing an immunogenic response to GnRH-I without cross-reactivity to other GnRH isoforms.

Vaccine·2005
Same author

Effects of GnRH immunization in sexually mature pony stallions.

Animal reproduction science·2005
Same author

New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.

Molecular diversity·2004
Same author

Design of synthetic peptides for diagnostics.

Current protein & peptide science·2003
Same journal

An attempt at measuring health in nucleus and multiplier pig farms.

Livestock production science·2020
Same journal

Application of monoclonal antibodies in animal production: A review.

Livestock production science·2020
Same journal

Problems of calf rearing in connection with their mortality and optimal growth: A review.

Livestock production science·2020
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

Murine Model of Epicutaneously-Induced Immunomodulation
09:06

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

356

Basic aspects of immunomodulation through active immunization.

R H Meloen1

  • 1Institute for Animal Science and Health (ID-DLO) P.O. Box 65, NL-8200 AB Lelystad, The Netherlands.

Livestock Production Science
|April 15, 2020
PubMed
Summary
This summary is machine-generated.

Active vaccination-based immunomodulation has advanced significantly, merging with mainstream vaccinology. Overcoming challenges like low immunogenicity of self-antigens, new vaccines are emerging for veterinary and human applications, including fertility control and cancer therapy.

Keywords:
ImmunomodulationImmunotoleranceSelf antigenVaccine

More Related Videos

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

9.7K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K

Related Experiment Videos

Last Updated: Dec 24, 2025

Murine Model of Epicutaneously-Induced Immunomodulation
09:06

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

356
Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

9.7K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K

Area of Science:

  • Immunology and Vaccinology
  • Biotechnology and Therapeutics

Background:

  • Immunomodulation via active vaccination has historically progressed separately from mainstream immunology.
  • Recent advancements in vaccinology have facilitated the integration of immunomodulation strategies.
  • A key challenge has been the low immunogenicity of self-antigens, hindering effective active vaccination.

Purpose of the Study:

  • To review the evolution of active vaccination-based immunomodulation over the past 25 years.
  • To highlight the integration of immunomodulation with modern vaccinology.
  • To discuss the progress in overcoming self-antigen immunogenicity and its implications for future vaccines.

Main Methods:

  • Review of scientific literature and vaccine development trends in immunomodulation.
  • Analysis of advancements in overcoming self-antigen recognition challenges.
  • Examination of progress in veterinary applications to inform human therapeutic design.

Main Results:

  • The first immunomodulation vaccine is now available, with others nearing market entry.
  • Significant progress has been made in addressing the low immunogenicity of self-antigens.
  • Veterinary applications have yielded practical rules for breaking immunotolerance.

Conclusions:

  • Active vaccination-based immunomodulation has matured and merged with contemporary vaccinology.
  • The development of novel immunomodulation vaccines is accelerating, driven by solved immunogenicity issues.
  • Insights from veterinary successes are expected to guide the design of human vaccines for fertility control and cancer treatment.